Last $0.0022 USD
Change Today 0.00 / 0.00%
Volume 0.0
XCHO On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 06/13/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

6001 Broken Sound Parkway

Suite 630

Boca Raton, FL 33487

United States

Phone: 561-496-6676

Fax: 561-998-8182

XenaCare Holdings, Inc. formulates, markets, and distributes a line of clinical and protective nutrition supplement products (NSPs), as well as homeopathic medication, detoxification, and pet care products. Products The company’s clinical NSP product group includes its proprietary formulations, such as XenaCor for the lowering of serum cholesterol, C-reactive protein, and homocysteine levels that support cardiovascular health; XenaTri for the lowering of triglycerides and raising of HDL that supports cardiovascular health; and XenaZyme Plus, which increases the body’s oxygen carrying capacities that support digestion. The company’s protective NSP product group is directed to the energy/lifestyle performance market. Its product, SunPill, is formulated to protect the skin when exposed to damaging ultraviolet rays. The company’s homeopathic medication product line primarily includes Cobroxin. Cobroxin is the first opiate and acetaminophen-free pain reliever available as an over-the-counter formulation clinically proven to treat moderate to severe (Stage 2) pain. Available in a topical gel that relieves pain associated with joints, repetitive stress, and arthritis; and in an oral spray that is formulated to relieve lower back pain, migraines, neck aches, shoulder pain, cramps, and neuralgia. Cobroxin is a derivative of cobra venom. The company’s detoxification product line primarily includes Zeolite. It markets and distributes Zeolite from Mineral Sciences, LLC within the United States. Zeolite is a cellular cleanse and detoxification product designed as a solution for removing heavy metals and toxins from the body. Additionally, this product improves nutrient absorption, supports immune system function, and reduces symptoms of allergies. The company’s new pet care product line is led by EstraPet. EstraPet is a treatment for domestic animals having sex hormone deficiencies utilizing patent pending process of Soy Germ Isoflavones. EstraPet answers the need for treating the unintended consequences caused by spaying and neutering. The company markets and distributes its products through various retail outlets, including chain drug stores, independent pharmacies, grocery chains, mass marketers, catalog companies, and e-commerce sites. Competition The company competes with national chain stores, such as GNC and Vitamin Shoppe. History XenaCare Holdings, Inc. was founded in 2001.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XCHO:US $0.00 USD 0.00

XCHO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for XCHO.
View Industry Companies
 

Industry Analysis

XCHO

Industry Average

Valuation XCHO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XENACARE HOLDINGS INC, please visit www.xenacareholdings.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.